MOLECULAR BIOLOGY OF PREVALENT DISEASES CTS981
The Molecular Biology of Prevalent Diseases CTS 981 research group is a multidisciplinary group composed of basic and clinical researchers whose objective is the study of prevalent diseases in the context of biomedical research. It has a scientific production of 311 articles in indexed international journals, 258 conference communications and has participated in 58 projects, mainly in national calls. The main lines of research range from the study of the metagenome, metabolome and transcriptome epigenome of diabetes and obesity in both adults and children, breast cancer, surgery for pancreatic and liver cancer, to the study of the molecular mechanisms responsible. of the pathophysiology of metabolism.
- Microbiome, metabolic diseases and cancer: detection of new biomarkers.
- Study of molecular markers of insulin resistance in morbid obese patients.
- Assessment of postprandial Lipemia.
- Epigenetics of pathological states.
- Studies of intervention in nutritional, obesity and diabetes.
- Molecular diagnosis and metabolism of infectious diseases and Oxidative stress in metabolic diseases.
- Male hypogonadism and obesity. Diabetic kidney disease, nephropathy associated with obesity.
- Cancer surgery: pancreas tumors, liver tumors. Infection in the surgical patient.
- Scientific-technical advice in intervention studies.
- Advice in independent clinical trials.
- Studies of the metagenome and epigenome.
- Scientific-technical advice in studies with animal’s models.
Key areasagri-food health nutrition
Main Researcher: MARIA ISABEL QUEIPO ORTU?O
PAI Reference: CTS981